This book draws together the entire spectrum of the relevant psychosocial dimensions and data necessary to adequately assist in the evaluation and treatment of patients who may be candidates for bariatric surgery.
Psychiatric Times presents exclusive coverage of the American Psychiatric Association Conference. Here we will report the latest news, resources, and updates from the 2013 APA Conference, the 166th Annual Meeting of the American Psychiatric Association, May 18-22, 2013, in San Francisco, CA. Read More
Test your diagnostic skills and knowledge by quickly identifying and assessing various mental health disorders. The Psychiatric Times Diagnostic Champions' Challenge is meant to educate and entertain. Test your clinical acumen in this activity that is sure to make you think.… Read More
The dramatic series of recent school shootings in nearly every region of the country has forever altered the way American society views its children. Fueled by media accounts that convey the drama of kids out of control, politicians, public policymakers, school administrators and parents now struggle for answers.
A New Drug Application was submitted to the U.S. Food and Drug Administration in May for the selective norepinephrine reuptake inhibitor (SNRI) antidepressant, reboxetine. The manufacturer, Pharmacia & Upjohn, has marketed the antidepressant as Edronax in the United Kingdom since July 1997, and in October 1997 received approval through the European Mutual Recognition Procedure to distribute it in 11 other European Union Countries during 1998.
Among the specialized refugee population in the United States, there is little research on the gender differences in psychological distress, which is considerable. Southeast Asian refugee women have been identified as an at-risk group for developing serious psychiatric disorders primarily due to their premigration experiences.
In a surprising 7-2 ruling in May, the U.S. Supreme Court held that a condemned inmate was entitled to federal habeas corpus review of his death sentence based on claims of mental incompetence. Writing for the majority, Chief Justice William O. Rehnquist let stand a 9th U.S. Circuit Court of Appeals ruling that delayed the execution of an Arizona prisoner pending a sanity determination in federal court.
Just as the first scattered incidents of homicide involving urban children in the early 1980s were not isolated episodes precipitated by "criminally ill" children, the recent episodes of school homicide in nonurban middle-class America, including the massacre in Littleton, Colo., are not isolated incidents of violence involving seriously "mentally ill" children.
Dual agency often presents a confusing situation for the clinician who must simultaneously serve two separate roles in a legal case, such as a treatment role and a forensic role (Berger, 1997). The two roles have different purposes, procedures, relationships with the patient or evaluee, and different ethical principles.
Is it appropriate for physicians to accept assisted-death requests at face value, or should they be interpreted as clinical indications of suffering? Should physicians act on patient requests to die, or should they address patient needs through other measures? Such are the difficult questions facing most physicians today.
It is now obvious to most knowledgeable observers that managed care will transform the American health care system. Managed care brought competitive market forces into medicine, and demonstrated that the right financial initiatives can reverse a century of rising professional standards and make health care just another lean and mean downsizing industry.
A leader of a key mental illness patient advocacy group indirectly but pointedly criticized psychiatrists for the care they give schizophrenics. Laurie Flynn, the executive director of the National Alliance for the Mentally Ill (NAMI), said she was "appalled" by the results of face-to-face interviews with over 700 schizophrenics during a 16-month period. The interviews turned up evidence of under- and overdosing of patients and a failure to get patients into effective community treatment plans.
Comments from your peers on our website and across our social media sites:
DSM-5: If You Don't Like the Effects, Look at the Causes •“‘Post-modern’” outlook on psychiatric diagnosis often leads to cynicism and nihilism—as if to say, ‘Nobody really knows anything about anything, and we shouldn’t trust anybody!’ Actually, there is a good deal of secure and well-founded scientific knowledge in psychiatry. ” Add your response...
Migraine and Psychiatric Comorbidity •“Sleep-related bruxism is high among those with fibromyalgia, anxiety, and migraines—but it is often overlooked as a dental problem. A long-acting benzodiazepine at night can make a big difference in patients with migraines who clinch or grind their teeth.” Add your response...
Can a Suicide Scale Predict the Unpredictable? •“The multifaceted nature of suicide requires both formal tools indicated in this article, as well as an awareness of changes in the patient (eg, outlook, behavior, attitude)—these and other factors may indicate suicide risk.” Add your response...
Eco-psychiatry? If you’re thinking, “Aren’t I already dealing with a lot in my daily practice?” you are invited to spend the next few minutes listening to what Dr Steven Moffic has to say about how the environment may be affecting your patients and what impact ecologically-related syndromes might have on DSM-5.
Thinking about suicidal behavior as a diagnosable problem will help bridge the gap in how psychiatrists think about suicidality and how it is perceived by patients and their families. Dr Maria Oquendo elaborates in this video.
ADHD can persist into adulthood and have a significant impact on a person's relationships, careers, and even safety. The ASRS (Adult ADHD Self-Report Scale) is a checklist of 18 questions about symptoms that are based on the diagnostic criteria of DSM-IV. The patient answers the questions and a positive score suggests the need for a thorough clinical evaluation with a healthcare professional.
The Bipolar Spectrum Diagnostic Scale (BSDS) was developed by Ronald Pies, MD and was later refined and tested by S. Nassir Ghaemi, MD, MPH and colleagues. The BSDS arose from Pies’s experience as a psychopharmacology consultant, where he was frequently called on to manage cases of “treatment-resistant depression.” In Pies’s experience, most of these cases eventually proved to be undiagnosed bipolar spectrum disorder.